bims-netuvo Biomed News
on Nerves in tumours of visceral organs
Issue of 2026–01–18
four papers selected by
Maksym V. Kopanitsa, Charles River Laboratories



  1. Cancer Res. 2026 Jan 14.
      The immunosuppressive tumor microenvironment (TME) enables cancer cells to evade clinical immunotherapies. Neural networks are vital components of the TME, and interactions between cancer cells, neuronal cells, and immune cells mediate immunosuppression. Hence, understanding the mechanisms of intercellular crosstalk could inform immunomodulatory approaches to enhance immunotherapy efficacy. Here, we found that the vagus nerve regulated the crosstalk between gastric cancer (GC) cells and group 3 innate lymphoid cells (ILC3s), boosting immune resistance in GC by enhancing programmed death ligand 1 (PD-L1) expression. Specifically, the infiltrated vagus nerve released acetylcholine (ACh) that elevated the expression of lipase ABHD16A in GC cells, facilitating the production and secretion of the metabolite lysophosphatidylserine (LysoPS) into the TME. LysoPS facilitated the proliferation and activation of ILC3s in TME, resulting in production of the cytokine interleukin (IL)-22 via the GPR34/AKT/STAT3 axis. In turn, IL-22 triggered the unfolded protein response (UPR) in GC cells, which led to an increase in PD-L1 expression that enhanced immune resistance. Importantly, targeting ACh or the crosstalk between GC cells and ILC3s significantly enhanced the efficacy of anti-PD-L1 immunotherapy. Serum levels of LysoPS and IL-22 were elevated in GC patients, particularly those with perineural invasion. Collectively, these findings provide valuable insights into the crosstalk between GC cells, nerve cells, and ILC3s that regulates immunosuppression and response to ant-PD-L1 immunotherapy, emphasizing the potential clinical significance of this axis for detecting and treating GC.
    DOI:  https://doi.org/10.1158/0008-5472.CAN-25-3092
  2. Brain Behav Immun. 2026 Jan 12. pii: S0889-1591(26)00028-0. [Epub ahead of print] 106280
       OBJECTIVE: Perineural invasion - a hallmark of cancers such as prostate and pancreatic - is strongly associated with severe, treatment-resistant pain. To dissect the neuron-specific mechanisms underlying this pain, we established a rat model of prostate cancer-associated perineural invasion to get insights into neuroinflammatory processes arising from direct tumor-nerve interactions and to provide a platform for evaluating targeted therapeutic strategies.
    METHODS: GFP-expressing AT-1 prostate cancer cells were directly microinjected into the perineurium of the sciatic nerve in syngeneic Copenhagen rats. Over 21 days, we assessed tumor progression, macrophage infiltration, and expression of pro-tumorigenic and pro-inflammatory mediators. Nociceptive behavior was monitored for mechanical, heat and cold stimuli. The MEK/ERK pathway was inhibited pharmacologically using the intrathecal phosphor-ERK1/2 inhibitor.
    RESULTS: Perineural AT-1 cell injection induced progressive tumor growth accompanied by increased polarized macrophage infiltration with a predominance of M1 macrophages and their associated pro-inflammatory cytokines (IL-1β, TNF-α). This response was further characterized by elevated levels of pro-tumorigenic (RANTES, IL-1ra, TIMP-1, VEGF, Ki67) along with upregulation of neuronal injury markers (ATF-3, NGF, and GDNF) in the sciatic nerve. In parallel, sustained upregulation of cAMP as well as phosphorylation of CREB and ERK1/2 along pain pathways over 21 days. Mechanical and heat hyperalgesia as well as cold allodynia progressively intensified over 21 days, was correlating with progressively intensified mechanical and cold allodynia. Importantly, MEK/ERK inhibition with intrathecal PD98059 reversed perineural tumor-induced mechanical allodynia.
    CONCLUSION: This model provides insight into neuroinflammatory tumor-macrophage-nerve interactions associated with neuronal hyperexcitability. Although focused in scope, it enables stepwise investigation of tumor-induced neuronal responses and offers a useful platform for evaluating neuroinflammatory mechanisms of tumor invasion and for identifying potential therapeutic targets.
    Keywords:  Nociception; Perineurial invasion; Prostate cancer; Sensory neuron; Tumor-associated macrophages
    DOI:  https://doi.org/10.1016/j.bbi.2026.106280